3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
995
Sarcoma
149
Lymphoid
28
Gastrointestinal
20
Genitourinary
15
Dermatologic
12
Thoracic
11
Breast
11
Endocrine
10
Other hematologic neoplasm
8
Head & Neck
7
Gynecologic
6
Other solid neoplasm
5
Classical hematology
5
Plasma cell
3
NET
2
Myeloid
2
Conditions
Neuroendocrine Tumors
378
Carcinoid Tumor
40
Gastro-enteropancreatic neuroendocrine tumor
36
Pancreatic Neoplasms
27
Carcinoma, Neuroendocrine
27
Neoplasms
25
Adenoma, Islet Cell
23
Pheochromocytoma
17
Paraganglioma
17
Neoplasm Metastasis
17
Stomach Neoplasms
15
Neuroblastoma
14
Gastrointestinal Neoplasms
14
Carcinoma, Hepatocellular
12
Thyroid Neoplasms
11
Prostatic Neoplasms
11
Breast Neoplasms
11
Sarcoma
10
Esophageal Neoplasms
10
Colorectal Neoplasms
10
Lung Neoplasms
9
Rectal Neoplasms
8
Gastrointestinal Stromal Tumors
8
Cholangiocarcinoma
8
Carcinoma, Medullary
8
Carcinoma
8
Brain Neoplasms
8
Anus Neoplasms
8
Liver Neoplasms
7
Colonic Neoplasms
7
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Glioma
×
NET
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled
NCT05500391
2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2
Recruiting
88 enrolled